IntelGenx Announces Shareholder Approval of atai Investment

Exploring Oregon’s Measure 110 and The Future of Drug Policy Reform

IntelGenx Expands Psychedelics Collaboration with atai Life Sciences with Signing of...

Henrik Dahl’s Review of Pickard’s ‘The Rose of Paracelsus: On Secrets...

Numinus Wellness and Optimi Health Submit All-Natural Psilocybin Extract to Health...

PT243 – Dr. Fernando Espi Forcen and Dr. Franklin King of...

CB Therapeutics Closes on Oversubscribed Series A

Psychedelic Therapy for Borderline Personality Disorder?

Psychedelics Today’s 5th Birthday Party

Numinus Congratulates MAPS on Phase 3 Clinical Trial Demonstrating Significant Benefits...

Load more